Literature DB >> 8968238

Late selective termination of fetal abnormalities in twin pregnancies: a multicentre report.

S Lipitz1, E Shalev, I Meizner, S Yagel, Z Weinraub, A Jaffa, J Shalev, R Achiron, E Schiff.   

Abstract

OBJECTIVE: To evaluate the outcome of late selective fetal termination based on combined data from eight tertiary perinatal centres.
DESIGN: Israeli law requires institutional committee approval for pregnancy termination. Moreover, after 24 weeks only a district superior committee can approve the termination. A total of 36 bichorionic twin pregnancies who underwent selective fetal termination after 24 complete gestational weeks were identified in eight Israeli centres.
RESULTS: In 23 women (63.9%) the indication for selective termination was structural anomaly, and in 13 (36.1%) the indication was chromosomal abnormality. The mean gestational age at the time of diagnosis was 24.1 +/- 1.9 weeks. The termination procedure was performed at a mean gestational age of 25.5 +/- 2.0 weeks (median 25, range 24-33 weeks). There was one case of immediate procedure-related complication (i.e. amnionitis) and the unaffected infant died, which was the only perinatal death in this series. No evidence of coagulopathy was reported. Only five women (13.8%) delivered before 34 completed weeks. The mean gestational age at delivery was 36.9 +/- 2.9 weeks (28-41 weeks), and the mean procedure-to-delivery interval was 11.8 +/- 3.2 weeks (median 13, range 3-17 weeks).
CONCLUSIONS: Late (> 24 weeks) selective termination in twin pregnancies is associated with favourable perinatal outcome of the healthy twin. In countries where the law permits late pregnancy termination, the parents should be informed of that possibility.

Entities:  

Mesh:

Year:  1996        PMID: 8968238     DOI: 10.1111/j.1471-0528.1996.tb09631.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  1 in total

1.  Dichorionic twins discordant for body-stalk anomaly: a management challenge.

Authors:  Rita Caldas; Cátia Rodrigues; Carla Pina; Rosete Nogueira
Journal:  BMJ Case Rep       Date:  2018-05-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.